Loblaw Stock: Buy, Sell, or Hold?

Loblaw (TSX:L) stock received multiple upgrades after earnings, but is it still worth your time as a long-term investment?

| More on:

Earnings season continues, and one stock continuing to demonstrate strength is Loblaw Companies (TSX:L). Loblaw stock recently reported its earnings for the second quarter (Q2) of 2024. The company demonstrated strong financial performance, driven by robust sales growth, effective cost management, and strategic investments in digital transformation and retail innovation.

Today, let’s examine whether the report really means Loblaw stock is a buy or whether the best has already come and gone.

What happened?

Loblaw stock is Canada’s largest food retailer, with operations spanning grocery stores, pharmacies, and financial services. Loblaw operates under various banners, including Loblaws, No Frills, and Shoppers Drug Mart, catering to a wide demographic range.

During its most recent second quarter 2024 earnings, there were many key points. Revenue hit $14.8 billion, up 6.5% compared to the same time last year. Net income also increased 8.2% to $515 million. Furthermore, earnings per share (EPS) came in at $1.45, up from $1.34 the year before. Its gross margin remained stable at 29.4%, with its operating margin up 5.9% to 6.2% year over year.

Overall, Loblaw’s revenue growth of 6.5% year over year shows strong consumer demand and successful promotional strategies. The increase in net income and EPS reflects effective cost management and operational efficiency. Stable gross margins coupled with improved operating margins highlight the company’s ability to maintain profitability despite inflationary pressures.

More to come?

That’s the question. And to discover the answer, we’ll have to look at strategic moves by Loblaw stock. Loblaw continues to invest in its digital infrastructure, enhancing its e-commerce platform, PC Optimum loyalty program, and supply chain capabilities. These investments are expected to drive long-term growth and improve customer experience.

The company’s pharmacy segment, led by Shoppers Drug Mart, has shown robust growth. The company’s emphasis on health and wellness, including its expanding range of health services and products, positions it well in a growing market segment.

Even so, Loblaw faces competition from other major Canadian retailers. Yet despite this competitive environment, Loblaw’s extensive network, strong brand portfolio, and diversified operations provide a significant competitive edge.

Valuation

So, is value there? Loblaw stock is currently trading at a price-to-earnings ratio of 25.2, which is a bit higher than the industry average. This suggests that the stock may be overvalued relative to its peers. However, the company’s finances paint another picture. Loblaw stock trades at 0.89 times sales, with an enterprise value over earnings before interest, taxes, depreciation, and amortization of 10.13. This would suggest the stock might be undervalued.

Furthermore, Loblaw stock also offers a dividend yield of 1.22%. This is well supported by a payout ratio of about 27%. So, considering Loblaw’s solid financial performance, strategic initiatives, and market position, the current valuation might present a potential buying opportunity for investors.

Bottom line

Overall, Loblaw stock has demonstrated strong financial performance and strategic foresight in addressing market trends and challenges. The company’s investments in digital transformation, sustainability, and health and wellness position it well for future growth. Given its solid fundamentals, competitive advantages, and attractive valuation, the stock still looks like a buy, especially considering recent analyst upgrades.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Dividend Stocks

Canadian flag
Dividend Stocks

High-Yield Alert: 3 Canadian Dividend Stocks to Buy Immediately

A high yield doesn't necessarily mean a stock is great, but in the case of these three, that's the truth.

Read more »

Investor wonders if it's safe to buy stocks now
Dividend Stocks

Is Magna International Stock a Buy for its 4.4% Dividend Yield?

Besides its 4.4% dividend yield, Magna’s solid fundamentals and long-term growth prospects make its stock really attractive for long-term investors.

Read more »

A worker gives a business presentation.
Dividend Stocks

2 Dividend-Growth Stocks Canadians Should Watch in November

These stocks have raised their dividends annually for decades.

Read more »

bulb idea thinking
Dividend Stocks

High-Yield Alert: 3 Canadian Dividend Stocks to Buy Now

Are you looking for high yields of 5-7%? You could consider buying these relatively low-risk Canadian dividend stocks at their…

Read more »

ways to boost income
Dividend Stocks

2 High-Yield Dividend Stocks That Are Screaming Buys Right Now 

These high-yield dividend stocks are trading at a discount due to short-term challenges. However, long-term growth potential is strong.

Read more »

An investor uses a tablet
Dividend Stocks

Where Will Saputo Stock Be in 3 Years?

Here are the key fundamental factors that could influence Saputo stock’s price movement in the next three years.

Read more »

Caution, careful
Dividend Stocks

3 Major Red Flags the CRA Is Watching for Every TFSA Holder

The CRA is always watching, but especially these major red flags. Here's an easy way to avoid them.

Read more »

The sun sets behind a power source
Dividend Stocks

Where Will Fortis Stock Be in 5 Years?

With interest rates declining and Fortis's dividend expected to grow at least 4% annually through 2029, is it worth buying…

Read more »